International Conference on Personalized Oncology
12 October 2017
I.M.Sechenov First Moscow State Medical University, Moscow

Program

Symposium
Personalized Oncology:
Through the View of Idea, Practice, Health and Translational Pipelines
Moscow October 12, 2017

 

10.00-10.15 OPENING

Introductory

10.15-10.45

Sergey Suchkov
Personalized Medicine (PM) through the View of Modern Philosophy to suit Healthcare Model and Translational Armamentarium to secure the latter: from The Past through the Future
Center for Personalized Medicine, I.M.Sechenov First Moscow State Medical University (Sechenov University) and Dept for Translational Medicine, Moscow Engineering Physical Institute (MEPhI), Russia; EPMA, Brussels, EU; PMC & ACS, Washington, DC, USA; ISPM, Tokyo, Japan

 

10.45-11.15

John Mendelsohn
Precision Cancer Medicine: Achievements and Prospects
Institute of Personalized Cancer Therapy & Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, Houston, USA

 

Fundamentals of Personalized and Precision Medicine

11.20-11.40

Roger Kamm
Microfluidic technologies for drug screening, point-of-care assays, and disease models: Applications to cancer
Mechanobiology & Microfluidics Laboratory and NSF Science and Technology Center on Emergent Behaviors of Integrated Cellular Systems, MIT, Cambridge, MA, USA

 

11.40-12.00

David Smith
Whole genome sequencing strategies for the treatment of patients with oropharyngeal squamous cell carci-noma
Department of Laboratory Medicine and Pathology and Chairman, Technology Assessment Group, Center for Individualized Medicine, Mayo Clinic, Rochester, MN, USA

 

12.00-12.20

Evgenyi Nikolaev
Proteomics as applicable to Oncology
Skolkovo Institute of Science and Technology, Moscow region, Moscow Institute of Physics and Technology, Dolgoprudnyj, Moscow region, Institute for Energy Problems of Chemical Physics Russian Academy of Sciences, Moscow

 

12.20-12.40

Carlos Malpica
Precision Metabolomics applied to Personalized Oncology
European Director, Metabolon Inc., Madrid, Spain

 

12.40-13.00

Nikolai Bovin
Personalized oncology through the View of The Diagnostic and Therapeutic Resources of the Newest Generation
Division for Chemical Biology of Glycans and Lipids, Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia, and CSO, KODE Biotech, Auckland, New Zealand

 

13.00-13.20

Shawn Murphy
Integrating Genomic and Clinical Data for Precision Medicine
Harvard Medical School, Research Information Systems and Computing, Partners HealthCare and Massachusetts General Hospital, Boston, MA, USA

 

Modern Clinical Models in Personalized Oncology

13.20-13.40

Marina Sekacheva
Personalized Treatment to target colorectal cancer 2.0: from RAS through Multitargeting
Center for Personalized Oncology, I.M.Sechenov First Moscow State Medical University, Moscow, Russia

 

13.40-14.00

Vladimir Lazar
Development and validation of a new technology and biomarker strategy to predict the efficacy of combinations of targeted cancer therapies: The Model of Lung Cancer
WIN Consortium, Paris, France

 

14.00-14.20

Evgeniya Kogan and Sofia Demura
Pathomorphology and Its Armamentarium as applicable to Personalized Oncology: Diagnostic, Predictive and Prognostic Protocols to Monitor Lung Cancer Development
I.M.Sechenov First Moscow State Medical University and Aston Group, Moscow,Russia

 

14.20-14.40

Chui Woo Kim
Smart Cancer Screening: A Tool for Personalized Medicine
Bioinfra and Professor, Seoul National University (SNU) and SNU College of Medicine Research Center, Seoul, South Korea

 

14.40-15.00

Hans Lentzen
From an Attractive Academic Idea and Promising Pharma Model through a step of Basic Research and Translational Bridging to suit Precision medicine – an example for Interdisciplinary Cooperation in Personalized Oncology
MELEMA Pharma GmbH, Hamburg-Cologne, Germany

 

CLOSING